Dariohealth announces two new employer contracts

New accounts demonstrate continued demand for integrated and holistic digital chronic condition management solutions new york , sept. 20, 2022 /prnewswire/ -- dariohealth corp. (nasdaq: drio) (the "company" or "dario"), a leader in the global digital therapeutics (dtx) market, announced today two new employer contracts, including one for the full suite of integrated solutions.
DRIO Ratings Summary
DRIO Quant Ranking